These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
756 related items for PubMed ID: 22522090
41. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T. Gut; 2013 May; 62(5):689-94. PubMed ID: 22961677 [Abstract] [Full Text] [Related]
42. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Torres J, Pineton de Chambrun G, Itzkowitz S, Sachar DB, Colombel JF. Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821 [Abstract] [Full Text] [Related]
43. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis. Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW. Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429 [Abstract] [Full Text] [Related]
45. Risk of colorectal cancer in ulcerative colitis in India. Venkataraman S, Mohan V, Ramakrishna BS, Peter S, Chacko A, Chandy G, Kurian G, Kurian S, Mathan M, Mathan VI, Patra S, Pulimood A, Rolston DD. J Gastroenterol Hepatol; 2005 May; 20(5):705-9. PubMed ID: 15853982 [Abstract] [Full Text] [Related]
46. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study. Olén O, Erichsen R, Sachs MC, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sørensen HT, Ludvigsson JF. Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530 [Abstract] [Full Text] [Related]
47. Malignancy in Crohn's disease: incidence and clinical characteristics in Japan. Mizushima T, Ohno Y, Nakajima K, Kai Y, Iijima H, Sekimoto M, Nishida T, Nezu R, Ito T, Doki Y, Mori M. Digestion; 2010 May; 81(4):265-70. PubMed ID: 20134166 [Abstract] [Full Text] [Related]
48. Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn's and ulcerative colitis. Averboukh F, Ziv Y, Kariv Y, Zmora O, Dotan I, Klausner JM, Rabau M, Tulchinsky H. Colorectal Dis; 2011 Nov; 13(11):1230-5. PubMed ID: 21689324 [Abstract] [Full Text] [Related]
49. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662 [Abstract] [Full Text] [Related]
50. Colorectal cancer complicating inflammatory bowel disease: a comparative study of Crohn's disease vs ulcerative colitis in 34 patients. Ouaïssi M, Maggiori L, Alves A, Giger U, Sielezneff I, Valleur P, Sastre B, Panis Y. Colorectal Dis; 2011 Jun; 13(6):684-8. PubMed ID: 20184639 [Abstract] [Full Text] [Related]
51. Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease. Juillerat P, Schneeweiss S, Cook EF, Ananthakrishnan AN, Mogun H, Korzenik JR. Aliment Pharmacol Ther; 2012 Aug; 36(3):239-47. PubMed ID: 22670722 [Abstract] [Full Text] [Related]
52. Mortality in inflammatory bowel disease patients under 65 years of age. O'Toole A, Walsh P, Keegan D, Byrne K, Doherty G, O'Donoghue D, Mulcahy H. Scand J Gastroenterol; 2014 Jul; 49(7):814-9. PubMed ID: 24730394 [Abstract] [Full Text] [Related]